Genentech Inc.

Case Activity (11994)

1. Misc | Filed: September 21, 2018 | Entered: September 21, 2018 Genentech, Inc. et al v. Amgen, Inc.

   Patent | Delaware

   Letter

   Letter to The Honorable Colm F. Connolly from James L. Higgins on behalf of Defendant regarding follow-up to counsel's call to Chambers on dispute about claim narrowing under Scheduling Order. (Attachments: # 1 Text of Proposed Order)(Higgins, James)

2. Misc | Filed: September 21, 2018 | Entered: September 21, 2018 Genentech, Inc. et al v. Amgen Inc.

   Patent | Delaware

   Letter

   Letter to The Honorable Colm F. Connolly from James L. Higgins on behalf of Defendant regarding follow-up to counsel's call to Chambers on dispute about claim narrowing under Scheduling Order. (Attachments: # 1 Text of Proposed Order)(Higgins, James)

3. Misc | Filed: September 21, 2018 | Entered: September 21, 2018 Genentech, Inc. et al v. Celltrion, Inc. et al

   Patent | Delaware

   Declaration

   DECLARATION re 23 Answering Brief in Opposition, (Declaration of Kevin J. DeJong) by Celltrion Healthcare Co., Ltd., Celltrion, Inc., Teva Pharmaceuticals International GmbH, Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Hoeschen, Nathan)